LTR Pharma and Aptar Pharma have entered into a co-development agreement for Spontan The primary goal is commercialisation of ...

Aptar said that adding Voluntis to its stable would allow help it develop a new generation of DTX for pharmaceutical and biotech customers, as well as other healthcare stakeholders including ...

The conference will open with a Welcome Cocktail Reception on the evening of Tuesday, May 6, and Aptar Pharma will sponsor a Gala Dinner at a scenic location in Estoril on Thursday, May 8.

Digitalisation of health is one of Chiesi's core R&D objectives, and the alliance with Aptar isn't its first in the respiratory category, its largest therapeutic area accounting for €1.7 billion ...

Aptar was recognized for its actions to cut emissions, mitigate climate risks and further the low-carbon economy, based on the data reported by the Company through CDP’s 2024 corporate ...